Pharmaceutical / Drug Definition :
Inhibits the enzyme DNA gyrase in susceptible gram-negative and gram-positive aerobic and anaerobic bacteria, interfering with bacterial DNA synthesis
FDA Label Requirements and Exceptions
Levofloxacin
FDA Import Information
Levofloxacin
FDA Detentions
Levofloxacin (Levofloxacin Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Levofloxacin (Levofloxacin Suppliers)
- Processors Levofloxacin
- Repackers Levofloxacin
- Relabelers Levofloxacin
- Exporters Levofloxacin
- Importers Levofloxacin
For more information about Levofloxacin, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
